Live feed
Filing
SC 13D/A
SC 13D/A0001062993-24-015470·Advent Life Sciences LLP
Schedule 13D ownership disclosure
Eloxx Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 29014R103
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 124,972
- Percent of class
- 3.9800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-24-015470
- Form type
- SC 13D/A
- Filer
- Advent Life Sciences LLP
- CIK
- CIK 1601364
- Filed
- Aug 20, 2024
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership